- Home
- HGTY vs INVA Comparison
HGTY vs INVA Comparison
Compare HGTY & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$19.41
Company Overview
Basic Information| Metric | HGTY | INVA |
|---|---|---|
| Founded | 1984 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | HGTY | INVA |
|---|---|---|
| Price | $12.65 | $19.41 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 5 |
| Target Price | $14.00 | ★ $36.80 |
| AVG Volume (30 Days) | 107.8K | ★ 855.5K |
| Earning Date | 03-03-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 241.11 | 53.96 |
| EPS | 0.36 | ★ 1.52 |
| Revenue | ★ $1,360,017,000.00 | $388,521,000.00 |
| Revenue This Year | $18.41 | $13.23 |
| Revenue Next Year | N/A | $8.58 |
| P/E Ratio | $35.18 | ★ $12.75 |
| Revenue Growth | ★ 17.92 | 10.14 |
| 52 Week Low | $8.03 | $16.52 |
| 52 Week High | $14.00 | $22.76 |
Technical Indicators
Market Signals| Indicator | HGTY | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 42.12 | 40.65 |
| Support Level | $12.50 | $19.00 |
| Resistance Level | $12.93 | $19.84 |
| Average True Range (ATR) | 0.40 | 0.49 |
| MACD | -0.09 | 0.00 |
| Stochastic Oscillator | 8.00 | 32.52 |
Price Performance
Historical Comparison HGTY
INVA
About HGTY Hagerty Inc.
Hagerty Inc is a provider of specialty automotive insurance. The company underwrites, sells, and services classic car and enthusiast vehicle insurance policies. Substantial revenue is derived from Commission and fees. Geographically it serves Europe, Canada, and the United States.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.